KinDex Pharmaceuticals competitors

KinDex Pharmaceuticals Competitors include Diffusion Pharmaceuticals, Vedanta Biosciences, Therapeutic Solutions International and Alzheon.
Add company...
KinDex Pharmaceuticals
KinDex Pharmaceuticals
KinDex was established to focus on the discovery and development of molecules that improve women’s health and impact chronic disease.
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals develops small molecule therapeutics for treating life-threatening medical conditions.
Vedanta Biosciences
Vedanta Biosciences
Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.
Therapeutic Solutions International
Therapeutic Solutions International
Therapeutic Solutions International focuses on immune modulation for the treatment of various diseases.
Alzheon
Alzheon
Alzheon is committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.
Founding Date
Founding Date
2009
Founding Date
2001
Founding Date
2010
Founding Date
2007
Founding Date
2013
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Charlottesville, US HQ
Locations
Cambridge, US HQ
Locations
Oceanside, US HQ
Locations
Framingham, US HQ
Employees
Employees
2
Employees
11
Employees
794% increase
Employees
357% decrease
Employees
109% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
10.4 m
Valuation ($)
N/A
Valuation ($)
5.5 m
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
110
Twitter followers
506
Twitter followers
N/A
Twitter followers
137

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$5k (FY, 2016)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($1.4m) (FY, 2017)
Net income
N/A
Net income
($1.1m) (FY, 2016)
Net income
($5.5m) (FY, 2017)

Funding

Latest funding round
Latest funding round
$ 327.3k (over 2 years ago)
Latest funding round
N/A
Latest funding round
$ 50m (over 2 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 5.8m
Total funding raised
N/A
Total funding raised
$ 50m
Total funding raised
N/A
Total funding raised
$ 37.1m
For sources of this data, please see the company profileDownload Excel

View company profiles

Diffusion Pharmaceuticals
HQ
Charlottesville, US
Employees
11

Diffusion Pharmaceuticals develops small molecule therapeutics for treating life-threatening medical conditions.

View company
Vedanta Biosciences
HQ
Cambridge, US
Employees
79↑ 4% increase

Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.

View company
Therapeutic Solutions International
HQ
Oceanside, US
Employees
3

Therapeutic Solutions International focuses on immune modulation for the treatment of various diseases.

View company
Alzheon
HQ
Framingham, US
Employees
10↓ 9% decrease

Alzheon is committed to developing breakthrough medicines for patients suffering from Alzheimer's disease and other neurological disorders.

View company